transparent gif


Ej inloggad.

Göteborgs universitets publikationer

Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience

Författare och institution:
M. Lehto (-); S. Snapinn (-); K. Dickstein (-); Karl Swedberg (Hjärt-kärlinstitutionen); M. S. Nieminen (-)
Publicerad i:
European heart journal, 26 ( 4 ) s. 350-6
0195-668X (Print)
Artikel, refereegranskad vetenskaplig
Sammanfattning (abstract):
AIMS: The present study aimed to determine the frequency and the impact on clinical outcome of atrial fibrillation (AF) in patients with acute myocardial infarction (AMI) and left ventricular dysfunction. METHODS AND RESULTS: In the OPTIMAAL trial, 5477 patients with AMI and signs of left ventricular dysfunction were included. At baseline, 655 patients (12%) had AF, and 345 (7.2%) developed new-onset AF during follow-up (2.7 +/- 0.9 years). Older patients, patients with history of angina and worse Killip class had and developed AF more frequently (P < 0.001). Patients with AF at baseline were at increased risk relative to those without AF for mortality [adjusted hazard ratio (HR) of 1.32, P = 0.001] and for stroke (HR 1.77, P < 0.001). New-onset AF was associated with increased subsequent mortality for the first 30 days following randomization (HR 3.83, P < 0.001) and the entire trial period (HR 1.82, P < 0.001). Risk of stroke was increased for the first 30 days (HR 14.6, P < 0.001) and for the whole trial period (HR 2.29, P < 0.001). CONCLUSION: AF is frequently observed in patients with AMI complicated by heart failure. Current AF, and the development of new AF soon after AMI, is associated with increased risk of death and stroke.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
Klinisk medicin ->
Aged, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Anti-Arrhythmia Agents/therapeutic use, Atrial Fibrillation/*etiology, Captopril/therapeutic use, Cerebrovascular Accident/etiology, Epidemiologic Methods, Female, Humans, Losartan/therapeutic use, Male, Middle Aged, Myocardial Infarction/*complications/drug therapy, Prognosis, Ventricular Dysfunction, Left/*complications
Postens nummer:
Posten skapad:
2007-10-09 10:51

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007